Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment
Abstract Depression has substantially increased in the last 10 years in Brazil, and mental health became a concerning issue for the public health globally, especially considering the COVID-19 pandemic. The therapeutic conduct in depression mainly relies on medication and psychotherapy. However, more...
Saved in:
Main Authors: | Rafaela Slaviero Pinheiro Cerdeira, Mario Hiroyuki Hirata |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2025-01-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100315&lng=en&tlng=en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of antidepressant treatment by pharmacogenomics: a case report
by: Ying Zhang, et al.
Published: (2025-01-01) -
Editorial: Pharmacogenetics of psychiatric disorders
by: Sarah Allegra, et al.
Published: (2025-01-01) -
Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
by: Borbón A, et al.
Published: (2025-01-01) -
Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
by: José A. G. Agúndez, et al.
Published: (2025-01-01) -
Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity
by: Jaeseong Oh, et al.
Published: (2018-09-01)